Evidence map›Paper›PMID 42457559›Full record

ArticlePhytotherapy research : PTR2026

Transcriptome Inference and Systematic Approaches to Investigate TCM Compounds With Beneficial Metabolic Effects.

Jing Li, Yang-Chi-Dung Lin, Hsi-Yuan Huang, Jihang Chen, Huali Zuo, Yun Tang, Hsien-Da Huang

Abstract read
In one paragraph

Article in Phytotherapy research : PTR, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jing LiSchool of Medicine, the Chinese University of Hong Kong, Shenzhen, Guangdong, PR China.
Yang-Chi-Dung LinSchool of Medicine, the Chinese University of Hong Kong, Shenzhen, Guangdong, PR China.
Hsi-Yuan HuangSchool of Medicine, the Chinese University of Hong Kong, Shenzhen, Guangdong, PR China.
Jihang ChenSchool of Medicine, the Chinese University of Hong Kong, Shenzhen, Guangdong, PR China.ORCID https://orcid.org/0009-0000-5692-8949
Huali ZuoSchool of Medicine, the Chinese University of Hong Kong, Shenzhen, Guangdong, PR China.
Yun TangInstitute of Bioinformatics and Systems Biology, College of Engineering Bioscience, National Yang Ming Chiao Tung University, Hsinchu, Taiwan.
Hsien-Da HuangSchool of Medicine, the Chinese University of Hong Kong, Shenzhen, Guangdong, PR China.ORCID https://orcid.org/0000-0003-2857-7023

Funding

Guangdong S&T Program 2024A0505050001Guangdong S&T Program 2024A0505050002Infinitus(China)Company Ltd. 2025E0155Science and Technology Plan Project of Shenzhen ZDCY20250901102000001Shenzhen Science and Technology Program JCYJ20250604141041017Shenzhen Science and Technology Program JCYJ20250604141235046the National Key R&D Program of China 2024YFE0104900Warshel Institute for Computational Biology funding from Shenzhen City and Longgang District LGKCSDPT2025001
6 · The paper itself

Abstract

Obesity is a major risk factor for type 2 diabetes. Some traditional Chinese medicine (TCM) compounds can improve obesity by increasing energy consumption. This study aimed to identify and verify TCM compounds that promote adipose thermogenesis to alleviate obesity via transcriptomic analysis, molecular docking, network pharmacology, and Connectivity Map (CMap) analysis. Thirty-six TCMs related to adipose tissue thermogenesis were first collected to generate transcriptomic data. Then a ranking method based on integrated transcriptomic data was used to select emodin from the TCM Da Huang for network pharmacology to explore its potential mechanisms and further experimental validation. CMap analysis of thermogenesis signature genes from ProFAT and GEO datasets identified triptolide as another compound for improving obesity through enhanced thermogenesis. In vitro experiments with 3T3-L1 cells and in vivo experiments with zebrafish were conducted. The results showed that both emodin and triptolide could upregulate the NAD

Indexed as

Drugs, Chinese HerbalObesityThermogenesisTranscriptome3T3-L1 CellsAdipose TissueAnimalsDiterpenesEmodinEpoxy CompoundsGene Expression ProfilingLipid MetabolismLipolysisMedicine, Chinese TraditionalMiceMolecular Docking SimulationDiterpenesDrugs, Chinese HerbalEmodinEpoxy CompoundsPhenanthrenestriptolideCMap analysismolecular dockingnetwork pharmacologyobesitytranscriptomic analysistype 2 diabetes mellitus

Identifiers

PMID42457559
PMCPMC13753672

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.